As we await some news. First a 30 minute chart of celg, its competitors, the biotech ETF (FBT) and (SPY). Celg is outperforming well over the last 15 days.
Also, for those who want to take a longer term focus of the stock is a monthly chart. Around 77.50 is the take out number from a technical standpoint.
The overall market still looks quite healthy as sector rotation is playing out, but a pullback of 3-5 % should be expected. Next week will be window dressing for the quarter, perhaps celg will be a must have in the portfolio as the quarter comes to a close!! GL
